# The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques

> **NCT01773512** · PHASE4 · UNKNOWN · sponsor: **General University Hospital, Prague** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01773512
- **Lead sponsor:** General University Hospital, Prague
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2014-12
- **Final completion:** 2015-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-01-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01773512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01773512, "The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01773512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*